Update on Omicron variant and its threat to vulnerable populations

© 2024 The Authors..

Objective: To reduce the incidence of severe illness and fatalities, and promote the awareness of protection and precaution, increased vaccination, strengthen the physical fitness, frequent ventilation, and health education should be enhanced among vulnerable populations as essential measures for the future control of COVID-19.

Study design: Systematic review.

Method: The search was done using PubMed, EMBASE and Web of Science for studies without language restrictions, published up through March 2023, since their authoritative and comprehensive literature search database. Eighty articles were included. Extraction of articles and quality assessment of included reviews was performed independently by two authors using the AMSTAR 2 score.

Results: The articles in the final data set included research on epidemiological characteristics, pathogenicity, available vaccines, treatments and epidemiological features in special populations including the elders, pregnant women, kids, people with chronic diseases concerning Omicron.

Conclusion: Although less pathogenic potential is found in Omicron, highly mutated forms have enhanced the ability of immune evasion and resistance to existing vaccines compared with former variants. Severe complications and outcomes may occur in vulnerable populations. Infected pregnant women are more likely to give birth prematurely, and fatal implications in children infected with Omicron are hyperimmune response and severe neurological disorders. In immunocompromised patients, there is a greater reported mortality and complication compared to patients with normal immune systems. Therefore, maintain social distancing, wear masks, and receive vaccinations are effective long-term measures.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:7

Enthalten in:

Public health in practice (Oxford, England) - 7(2024) vom: 30. Apr., Seite 100494

Sprache:

Englisch

Beteiligte Personen:

Dai, Bowen [VerfasserIn]
Ji, Wangquan [VerfasserIn]
Zhu, Peiyu [VerfasserIn]
Han, Shujie [VerfasserIn]
Chen, Yu [VerfasserIn]
Jin, Yuefei [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
Epidemiology
Journal Article
Omicron
Review
SARS-CoV-2
Vaccine

Anmerkungen:

Date Revised 09.04.2024

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.1016/j.puhip.2024.100494

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM370742206